In the Media

Writing for The New York Times, visiting scientist Mark Trusheim and Peter Bach of Memorial Sloan Kettering Cancer Center explore how to lower the cost of biologic drugs. “Prices of new drugs will continue to make headlines, as well they should,” they write. “But we must fix the problem that older biologic drugs have perpetually high prices, and do so by passing a law that ensures that at the appropriate time their prices fall fast, and they fall far.”